SCHEMBL13816424

SCHEMBL13816424

COC(=O)Cc1ccc(OC)c(C(=O)c2ccccc2N)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.51
▸ GAA P10253 2/20 0.51
▸ GFER P55789 1/20 0.51
▸ PTGDR2 Q9Y5Y4 2/20 0.49
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HPGD P15428 6/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ RCE1 Q9Y256 1/20 0.45
▸ CTSD P07339 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.44
▸ CFTR P13569 1/20 0.44
▸ MAPK13 O15264 1/20 0.44
▸ MAPK12 P53778 1/20 0.44
▸ MAPK11 Q15759 1/20 0.44
▸ MAPK14 Q16539 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ JAK2 O60674 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13816427 0.81 HTT (0.52) ALDH1A1PTGDR2HPGDLMNAMAPT
SCHEMBL13816489 0.79 LMNA (0.44) ALDH1A1GAAGFERPTGDR2CYP1A2
SCHEMBL7247237 0.79 ALDH1A1 (0.69) ALDH1A1GAAGFERCYP1A2CYP3A4
Hydrochloric Acid SCHEMBL6983661 0.78 ALDH1A1 (0.67) ALDH1A1GAAGFERCYP1A2CYP3A4
SCHEMBL10370235 0.77 ALDH1A1 (0.56) ALDH1A1GAAHPGDKDM4ERCE1
SCHEMBL5701107 0.76 ALDH1A1 (0.64) ALDH1A1GAAGFERCYP1A2CYP3A4
SCHEMBL7649762 0.75 ALDH1A1 (0.73) ALDH1A1GAAGFERHPGDKDM4E
SCHEMBL29626821 0.74 ALDH1A1 (0.62) ALDH1A1GAAGFERCYP1A2CYP3A4
SCHEMBL198282 0.74 ALDH1A1 (0.62) ALDH1A1GAAGFERCYP1A2CYP3A4
SCHEMBL2057149 0.74 ALDH1A1 (0.57) ALDH1A1GAAGFERCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541383-B2 Asthma and allergic inflammation modulators AMGEN INC. (US) 2009-06-02 — — US disclosed
US-7541383-B2 Asthma and allergic inflammation modulators AMGEN INC. (US) 2009-06-02 — — US disclosed
US-20080085891-A1 Asthma and allergic inflammation modulators FU ZICE 2008-04-10 — — US disclosed
US-20080085891-A1 Asthma and allergic inflammation modulators FU ZICE 2008-04-10 — — US disclosed
US-7321001-B2 Asthma and allergic inflammation modulators AMGEN INC. (US) 2008-01-22 — — US disclosed
US-7321001-B2 Asthma and allergic inflammation modulators AMGEN INC. (US) 2008-01-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085891-A1 Asthma and allergic inflammation modulators IL5, TSLP, CYSLTR2 ALDH1A1 763/4885GAA 3555/4885GFER 2418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback